Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2026-01-24 @ 8:12 PM
Study NCT ID:
NCT05464433
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-13
First Post:
2022-07-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-04
First Submit QC Date:
None
Study First Post Date:
2022-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-11
Last Update Post Date:
2025-03-13
Last Update Post Date Type:
ACTUAL